PE20080234A1 - Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas - Google Patents

Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas

Info

Publication number
PE20080234A1
PE20080234A1 PE2007000616A PE2007000616A PE20080234A1 PE 20080234 A1 PE20080234 A1 PE 20080234A1 PE 2007000616 A PE2007000616 A PE 2007000616A PE 2007000616 A PE2007000616 A PE 2007000616A PE 20080234 A1 PE20080234 A1 PE 20080234A1
Authority
PE
Peru
Prior art keywords
sulfamide
methyl
benzoheteroarylsulfamides
antiepileptic
derivatives
Prior art date
Application number
PE2007000616A
Other languages
English (en)
Inventor
Virginia L Smith-Swintosky
Michael H Parker
Allen B Reitz
Bruce E Maryanoff
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PE20080234A1 publication Critical patent/PE20080234A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Abstract

REFERIDA A UN DERIVADO DE BENZOHETEROARILSULFAMIDA DE FORMULA (I), DONDE R1 ES H, HALOGENO, OH, METOXI, NITRO, ENTRE OTROS; X-Y ES -S-CH-, -O-CH-, -O-C(CH3)-, ENTRE OTROS; A ES -CH2- O -CH(CH3)-; R2 ES H O METILO; R3 Y R4 SON H O ALQUILO C1-C4 O JUNTO CON EL ATOMO DE NITROGENO AL CUAL ESTAN UNIDOS FORMAN UN ANILLO DE 5 A 7 MIEMBROS OPCIONALMENTE SUSTITUIDO CON O, N O S. SON COMPUESTOS PREFERIDOS: N-(BENZO[b]TIEN-3-ILMETIL)-SULFAMIDA, N-[(5-CLOROBENZO[b]TIEN-3-IL)METIL]-SULFAMIDA, N-[(5-FLUOROBENZO[b]TIEN-3-IL)METIL]-SULFAMIDA, ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LA EPILEPSIA Y TRASTORNOS RELACIONADOS. TAMBIEN ESTA REFERIDA A UNA COMBINACION FARMACEUTICA QUE COMPRENDE LOS COMPUESTOS DE FORMULA (I) Y OTRO AGENTE ANTIEPILEPTICO TAL COMO CARBAMAZEPINA, CLOBAZAM, CLONAZEPAM, GABAPENTINA, FENITOINA, ENTRE OTROS
PE2007000616A 2006-05-19 2007-05-21 Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas PE20080234A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80200106P 2006-05-19 2006-05-19

Publications (1)

Publication Number Publication Date
PE20080234A1 true PE20080234A1 (es) 2008-04-25

Family

ID=38510389

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000616A PE20080234A1 (es) 2006-05-19 2007-05-21 Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas

Country Status (7)

Country Link
US (1) US20070293476A1 (es)
AR (1) AR061066A1 (es)
CL (1) CL2007001468A1 (es)
PE (1) PE20080234A1 (es)
TW (1) TW200812574A (es)
UY (1) UY30360A1 (es)
WO (1) WO2007137164A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200612905A (en) * 2004-06-16 2006-05-01 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2006127184A1 (en) * 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
AR058389A1 (es) * 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
AU2007253814A1 (en) * 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
EA019757B1 (ru) * 2006-06-15 2014-06-30 ЮСиБи ФАРМА ГМБХ Фармацевтическая композиция с синергетическим противосудорожным эффектом
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
AU2009271362B2 (en) 2008-06-23 2014-03-13 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CA2961410C (en) 2014-09-16 2023-07-11 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
WO2016118391A1 (en) 2015-01-25 2016-07-28 India Globalization Capital, Inc. Composition and method for treating seizure disorders
WO2017027651A1 (en) 2015-08-12 2017-02-16 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
CA3027862A1 (en) 2016-06-15 2017-12-21 India Globalization Capital, Inc. Method and composition for treating seizure disorders
EP3769759B1 (en) 2018-03-20 2023-11-15 Eisai R&D Management Co., Ltd. Combination of an indanesulfamide derivative with perampanel for use in the treatment of epilepsy
WO2024054807A1 (en) * 2022-09-06 2024-03-14 Biohaven Therapeutics Ltd. Combination therapies including metal channel activators and tdp-43 modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
WO1997019682A1 (en) * 1995-12-01 1997-06-05 Synaptic Pharmaceutical Corporation Aryl sulfonamide and sulfamide derivatives and uses thereof
CZ2002524A3 (cs) * 1999-08-20 2002-11-13 Ortho-Mcneil Pharmaceutical, Inc. Kompozice obsahující tramadol a antikonvulziva
CN1897950A (zh) * 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
EP1727538A2 (en) * 2004-02-13 2006-12-06 Neuromolecular Inc. Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
AU2005277134A1 (en) * 2004-08-24 2006-03-02 Janssen Pharmaceutica N.V. Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
US20070191460A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis

Also Published As

Publication number Publication date
TW200812574A (en) 2008-03-16
US20070293476A1 (en) 2007-12-20
WO2007137164A2 (en) 2007-11-29
UY30360A1 (es) 2007-08-31
CL2007001468A1 (es) 2008-04-04
AR061066A1 (es) 2008-07-30
WO2007137164A3 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
PE20080234A1 (es) Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas
PE20060500A1 (es) Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes
EA201490489A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
ECSP088871A (es) Derivados de triazolopirazina
GT200600028A (es) Compuestos y composiciones como inhibidores de proteina kinasa
ECSP066972A (es) Profármacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y métodos
DK1697371T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
DOP2003000566A (es) Cicloalcanindoles con sustitución con fluor, composiciones que contienen estos compuestos y metodos de preparación para un medicamento
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
PE20080155A1 (es) Compuestos heterociclicos como inhibidores de aspartil-proteasa
DOP2001000170A (es) Derivados de tiofeno utiles como agentes anticancesoros
ECSP088239A (es) Composición de liberación de fármaco sostenida
MA30765B1 (fr) Derives innovants du thiophene
PE20071251A1 (es) Derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
AR071959A1 (es) Derivado de benceno o tiofeno y su uso como inhibidor de vap-1
ECSP055582A (es) Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor
CR20110131A (es) Derivados de prostaglandinas
NI200900071A (es) Compuestos de pirozolina y su uso y composiciones farmacéuticas. pc 33496a.
PE20081781A1 (es) Agonistas de adrenoreceptores alfa2c funcionalmente selectivos
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
AR082155A1 (es) Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido
MA38679B1 (fr) Modulateurs du récepteur de cxcr7
AR059741A1 (es) Formulaciones farmaceuticas liquidas y semisolidas y procedimientos
NO20092230L (no) Azabicykliske heterocykler som cannabinoid reseptor modulatorer

Legal Events

Date Code Title Description
FC Refusal